Distinctive features of "chronotherapeutic" and "pulsatile" drug delivery systems negating the practice of their interchangeable terminology

Journal of Drug Targeting

Volumn 18, Issue 6, 2010, Pages 413-419

  Ali, Javed ^a   Baboota, Sanjula ^a   Ahuja, Alka ^a   Saigal, Nitin ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Barrier layer; Chronotherapeutic drug delivery; Multiple pulse systems; Pulsatile drug delivery; Release modifying polymers; Single pulse systems

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; POLYMER; PROPRANOLOL; UNCLASSIFIED DRUG; VERAPAMIL; VERELAN PM; DRUG;

CHRONOTHERAPY; CIRCADIAN RHYTHM; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG RELEASE; GASTROINTESTINAL TRACT; HUMAN; NOTE; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; TABLET FORMULATION; BLOOD; CHEMISTRY; CLASSIFICATION; DRUG PULSE THERAPY; MEDICINAL CHEMISTRY; NOMENCLATURE; PROCEDURES;

CHEMISTRY, PHARMACEUTICAL; DRUG CHRONOTHERAPY; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS; PULSE THERAPY, DRUG; TERMINOLOGY AS TOPIC;

EID: 77953263042     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003587250     Document Type: Note

References (21)

1. Anal AK. (2007). Stimuli-induced Pulsatile or Triggered Release Delivery Systems for Bioactive Compounds. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 1, 83-90.
2. Cha R, Rybak MJ. (2004). Pulsatile delivery of amoxicillin against Streptococcus pneumoniae. J Antimicrob Chemother, 54, 1067-1071.
3. Crison JR, Siersma PR, Lipka E, Taylor MD, Amidon GL. (1995). Programmable oral release technology PORT system: a novel dosage form for time and site specific oral drug delivery. Proc Int Symp Control Release Bioactive Mater, 22, 278-279.
4. Flanner H, Treacy D, Beth B. (2008). Modified release amoxicillin products. US20080132478.
5. Held K, Marolf T, Erni W. (1990). Principle and development of a tablet formulation with pulsatile drug delivery after a controlled and pH dependent latency period. Acta Pharm Technol, 36, 38s.
6. Kim B, Peppas NA. (2003). In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int J Pharm, 266, 29-37.
7. Klein S, Stein J, Dressman J. (2005). Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model. J Pharm Pharmacol, 57, 709-719.
8. Lee WW, Wilson CG, Mukherjee G. (2003). Time dependent systems for colonic delivery. In: Rathbone MJ, Hadgraft J, Roberts MS, ed. Modified release drug delivery technology. New York: Marcel Dekker, 247-248.
9. Lévi F. (2006). Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control, 17, 611-621.
10. Lerner I, Flashner M, Penhasi A. (2003). Immediate release gastrointestinal drug delivery system. US6531152B1.
11. Magruder P, Barclay B, Wong PSL, Theeuwes F. (1988). Composition comprising salbutamol. US4751071.
12. McNeill ME, Rashid A, Stevens HNE. (1993). Drug dispensing device. GB2230442.
13. Ross AC, MacRae RJ, Walther M, Stevens HN. (2000). Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol, 52, 903-909.
14. Rudnic E, Isbister J, Donald J. (2006). Multiple delayed released antibiotic product, use and formulation thereof. US7025989.
15. Saigal N, Baboota S, Ahuja A, Ali J. (2009a). Multiple-pulse drug delivery systems: setting a new paradigm for infectious disease therapy. Expert Opin Drug Deliv, 6, 441-452.
16. Saigal N, Baboota S, Ahuja A, Ali J. (2009b). Site specific chronotherapeutic drug delivery systems: a patent review. Recent Pat Drug Deliv Formul, 3, 64-70.
17. Shaw E, Tofler GH. (2009). Circadian rhythm and cardiovascular disease. Curr Atheroscler Rep, 11, 289-295.
18. Smith DH, Neutel JM, Weber MA. (2001). A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am J Hypertens, 14, 14-19.
19. Stevens HNE, Ross AC, Johnson JR. (2001). The hydrophilic-sandwich (HS) capsule: a convenient time delayed oral probe device. J Pharm Pharmacol, 52, s41.
20. Ueda Y, Hata T, Yamaguchi H. (1989). Time-controlled explosion systems. US4871549.
21. Wong PSL, Theeuwes P, Larsen SD. (1994). Osmotic device for delayed delivery of agent. US5312388.